Investival ShowcaseMonday, 17 November 2025 - GMT (Greenwich Mean Time, GMTZ)

The journey from groundbreaking scientific discovery to accessible patient treatment is fraught with challenges, requiring seamless collaboration between researchers, investors, industry leaders, and technology transfer professionals. This panel explores the critical success factors, common pitfalls, and innovative strategies that can accelerate the translation of promising research into therapies that genuinely transform patient outcomes and healthcare delivery

• Evaluating scientific discoveries for their commercial and clinical potential, including biomarker validation, target identification, and early proof-of-concept studies that de-risk the development pathway
• Exploring diverse funding mechanisms from (seed funding, Series A rounds etc), and strategic partnerships that sustain innovation through the lengthy development process
• Analysing successful models for academia-industry collaboration, the role of accelerators and incubators in bridging knowledge gaps, and how strategic alliances can overcome resource limitations while maintaining focus on patient-centric outcomes
• Pharma - Working with start-up companies and helping them de-risk, co-create and scale up their value proposition and supporting them in their commercialization